GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
+27.67%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$245M
AUM Growth
+$245M
Cap. Flow
+$59.9M
Cap. Flow %
24.47%
Top 10 Hldgs %
56.8%
Holding
43
New
12
Increased
11
Reduced
10
Closed
6

Top Buys

1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$18.2M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
$15.5M
3
RVNC
Revance Therapeutics, Inc.
RVNC
$10.5M
4
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
$6.98M
5
RLMD icon
Relmada Therapeutics
RLMD
$6.48M

Top Sells

1
SGEN
Seagen Inc. Common Stock
SGEN
$6.19M
2
MRUS icon
Merus
MRUS
$5.66M
3
FOLD icon
Amicus Therapeutics
FOLD
$5.22M
4
ARVN icon
Arvinas
ARVN
$4.63M
5
COGT icon
Cogent Biosciences
COGT
$4.48M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
JBIO
26
Jade Biosciences, Inc. Common Stock
JBIO
$245M
$2.49M 0.7%
+150,000
New +$2.49M
MLTX icon
27
MoonLake Immunotherapeutics
MLTX
$3.78B
$2.33M 0.65%
300,000
– –
RAPT icon
28
RAPT Therapeutics
RAPT
$187M
$2.17M 0.61%
90,000
-75,000
-45% -$1.8M
TCDA
29
DELISTED
Tricida, Inc. Common Stock
TCDA
$2.1M 0.59%
+200,000
New +$2.1M
TARS icon
30
Tarsus Pharmaceuticals
TARS
$2.44B
$2.05M 0.58%
120,000
– –
DSGN icon
31
Design Therapeutics
DSGN
$339M
$1.67M 0.47%
100,000
-175,000
-64% -$2.93M
MDGL icon
32
Madrigal Pharmaceuticals
MDGL
$9.7B
$1.63M 0.46%
+25,000
New +$1.63M
RYTM icon
33
Rhythm Pharmaceuticals
RYTM
$6.75B
$1.59M 0.45%
+65,000
New +$1.59M
BIIB icon
34
Biogen
BIIB
$20.8B
$1M 0.28%
+3,750
New +$1M
SYRE icon
35
Spyre Therapeutics
SYRE
$1.02B
$526K 0.15%
1,000,000
+75,000
+8% +$39.5K
NMTR
36
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
– –
-1,800,000
Closed -$469K
DICE
37
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-30,000
Closed -$466K
SGEN
38
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-35,000
Closed -$6.19M
XBI icon
39
SPDR S&P Biotech ETF
XBI
$5.29B
– –
0
– –
MRUS icon
40
Merus
MRUS
$5.04B
– –
-250,000
Closed -$5.66M
CLDX icon
41
Celldex Therapeutics
CLDX
$1.57B
– –
0
– –
ARVN icon
42
Arvinas
ARVN
$580M
– –
-110,000
Closed -$4.63M
ALNY icon
43
Alnylam Pharmaceuticals
ALNY
$58.6B
– –
-1,900
Closed -$277K
1
2